Funded Programmes

THE LATEST FUNDING NEWS IN Denmark

In Denmark, Movember funds support two areas:
  • ‘Team science’ prostate cancer research, involving the best researchers across Denmark in one collaborative project
  • Living with and beyond cancer information programs through PROPA, Denmark’s support group for those with prostate cancer and their friends and family
     

THE LATEST FUNDING NEWS IN DENMARK

To view all of the programmes being funded by the Movember Foundation, please see our Report Cards section. (English only)


Movember Foundation makes prostate cancer research grant announcement in Denmark

The Movember Foundation has recently announced that it will be offering up to €200,000 of funding to Prostate Cancer researchers in Denmark to complete a high impact prostate cancer research project as part of the Movember Foundations global programme of Prostate Cancer research.

The Movember Foundation is inviting applications from high quality, internationally recognised teams of researchers across Denmark and will be allocating funding later in 2015.

The proposed research will be addressing one or more of the Movember Foundations strategic priorities for the disease to improve the lives of men with prostate cancer.

It is expected that the research proposals will explore key issues in prostate cancer such as helping to avoid unnecessary treatments, reducing unpleasant side effects, reducing invasive testing methods, stopping or slowing the progression of the disease, developing clinical interventions and reducing variation in clinical quality; ultimately leading to a significant improvement on the lives of men with prostate cancer.

More information on the research project and information for Denmark based researchers can be found by emailing programs@movember.com


Prostate Cancer Breakthrough, November 2014

Research funded by the Movember Foundation has resulted in a scientific breakthrough with significant implications for men with prostate cancer. The research project, led by Professor Robert Bristow in Toronto, Canada, has found that men have a genetic “signature” that will identify prostate cancer patients who are at high risk of their cancer returning after primary treatment, such as surgery or radiotherapy. A new test will allow men to be offered a more personalised treatment plan, avoid unnecessary treatments and side effects, and will increase chances of survival.

The team was funded primarily by the Movember Foundation with a grant of CAD $15 million, which is largest donation we have made to a single research project. The findings have been published this month in the Lancet, one of the world’s leading medical journals, and the research team will now work with institutions across the globe to validate the test over the next 2-3 years.

  • Click here to watch the video of Professor Robert Bristow (English only).
  • Click here to learn more about prostate cancer

Movember Prostate Cancer National Advisory Committee

At a national level, to assist, identify and prioritise research areas in Denmark, Movember created the Movember Prostate Cancer National Advisory Committee in 2012. This advisory committee is responsible for providing Movember with both thought leadership and advice on the strategic direction of prostate cancer research in Denmark.
The committee is made up of the leaders in the Danish prostate cancer research community. It is chaired by M.D. Andreas Røder, from the Urology Research Unit & Department of Urology in Rigshospitalet, Copenhagen University Hospital.

The other members of the Committee are:
  • MD, PhD Andreas Røder, Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet. Copenhagen University Hospital
  • Professor Peter Iversen, Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet. Copenhagen University Hospital
  • Professor Michael Borre. Department of Urology, Skejby, Aarhus University Hospital
  • Consultant Søren Høyer, Department of Pathology, Skejby, Aarhus University Hospital
  • PMD, PhD Peter Meidahl, Department of Oncology, Rigshospitalet, Copenhagen University Hospital

Living with and beyond cancer - PROPA

Movember supports projects that focus on living with and surviving cancer through PROPA, the Danish patient association for prostate cancer patients and their families.

Read all about it: Movember’s global action plan news

By bringing together more than 250 of the world's top prostate and testicular cancer researchers, the Global Action Plan (GAP) facilitates a new and unprecedented level of global research collaboration, not previously seen within the cancer community.